Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

IrelandBack to Ireland

Clinical trials in Cork – page 13

159 clinical trials in Cork, Ireland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Cork at a glance
159
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

159 trials in Cork

Open in trial search

Breast cancer metastatic

Not recruiting

Study Comparing Olaparib and Pembrolizumab with Chemotherapy and Pembrolizumab for Patients with Advanced Triple-Negative Breast Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Triple negative breast cancer

Not recruiting

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Neoplasm

Not recruiting

Study of Olaparib for Patients with Advanced Cancer Having HRRm or HRD Mutations

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:Merck Sharp & Dohme LLC

Systemic mastocytosis

Not recruiting

Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide
  • Sponsor:Cogent Biosciences Inc.

Anti-glomerular basement membrane disease

Not recruiting

Study on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Hansa Biopharma AB

Fallopian tube cancer+1

Not recruiting

Study on Treatment for Recurrent Platinum-Sensitive Ovarian, Peritoneal, or Fallopian Tube Cancer Using Carboplatin and Mirvetuximab Soravtansine in Eligible Patients

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on the Effects of Atacicept in Adults with IgA Nephropathy

Not recruiting
Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Atacicept
  • Sponsor:Vera Therapeutics Inc.

COVID-19

Not recruiting

Study on the Effects of S-217622 for Adults Hospitalized with COVID-19

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:(6E)-6-[(6-Chloro-2-Methyl-2H-Indazol-5-Yl)Imino]-3-[(1-Methyl-1H-1,2,4-Triazol-3-Yl)Methyl]-1-[(2,4,5-Trifluorophenyl)Methyl]-1,3,5-Triazinane-2,4-Dione
  • Sponsor:University Of Minnesota

Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

Not recruiting
Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Novartis Pharma AG

Food allergy

Not recruiting

Study on the Effectiveness and Safety of DBV712 for Peanut Allergy in Children Aged 4-7

Registered drug
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Water For Injection
  • Sponsor:Dbv Technologies

Ovarian cancer recurrent

Not recruiting

Study of Pembrolizumab, Paclitaxel, and Bevacizumab for Patients with Platinum-Resistant Recurrent Ovarian Cancer

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Anhydrous Docetaxel
  • Sponsor:Merck Sharp & Dohme LLC

Bronchopulmonary dysplasia

Not recruiting

Study on Mecasermin Rinfabate for Preventing Chronic Lung Disease in Extremely Premature Babies

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Mecasermin Rinfabate
  • Sponsor:Ohb Neonatology Limited

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Cork

What the registry says about research in the country

01 Oncology Research

Extensive clinical trials focusing on lung cancer treatments, including innovative therapies for non-small cell lung cancer and testing new drug combinations. Studies evaluating treatments for breast cancer, particularly in hormone receptor-positive and HER2-negative variants.

  • Advanced Lung Cancer Treatments
  • Breast Cancer Therapies
  • Prostate Cancer Studies

Multiple trials exploring combination therapies and novel treatment approaches for various cancer types.

02 Hematologic Disorders

Research initiatives examining treatments for chronic lymphocytic leukemia and lymphomas. Studies evaluating new therapeutic approaches for myelodysplastic syndromes, focusing on reducing transfusion dependency.

  • Leukemia Treatments
  • Lymphoma Therapies
  • Blood Disorders Management

Innovative approaches combining multiple therapeutic agents to improve patient outcomes.

03 Autoimmune Conditions

Clinical studies investigating treatments for Primary Sjögren's Disease and atopic dermatitis. Research on novel therapeutic approaches for inflammatory conditions and immune system disorders.

  • Inflammatory Disease Treatments
  • Skin Condition Therapies
  • Immune System Modulation

Focus on developing targeted therapies to improve patient quality of life.

Back to IrelandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.